Hyun D. Kim

Corporate Officer/Principal bij EMBER THERAPEUTICS, INC.

Health Technology

Consumer Services

Actieve functies van Hyun D. Kim

Bedrijven	Functie	Begin	Einde
EMBER THERAPEUTICS, INC.	Corporate Officer/Principal	-	-
EMBER THERAPEUTICS, INC.	Hoofd Techniek/Wetenschap/O&O	-	-

Bedrijven	Functie	Begin	Einde
Olympus Biotech Corp. (United States)	Hoofd Techniek/Wetenschap/O&O	-	-
ANIKA THERAPEUTICS, INC.	Corporate Officer/Principal	-	-
Transport Pharmaceuticals, Inc. Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA.	Hoofd Techniek/Wetenschap/O&O	-	-
Ember Therapeutics, Inc. /Old/ Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY.	Corporate Officer/Principal	-	-

Brown University

Doctorate Degree

Internationaal

Verenigde Staten

Operationeel

Corporate Officer/Principal	3
Chief Tech/Sci/R&D Officer	3
Doctorate Degree	1

Sectoraal

Health Technology	5
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	2
EMBER THERAPEUTICS, INC.	Health Technology
ANIKA THERAPEUTICS, INC.	Health Technology

Bedrijven in privébezit	3
Ember Therapeutics, Inc. /Old/ Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY.	Health Technology
Transport Pharmaceuticals, Inc. Transport Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Transport Pharmaceuticals, Inc. engaged in the development of medical products for the treatment of multiple dermatological diseases. It developed iontophoretic technique to effect trans-dermal drug delivery for a number of dermatological conditions. The company was founded by Dennis I. Goldberg in 1999 and was headquartered in Framingham, MA.	Health Technology
Olympus Biotech Corp. (United States)